Organon BioSciences Overview
- Founded
- 1923
- Status
- Acquired/Merged
- Latest Deal Type
- M&A
- Financing Rounds
- 2
- Investments
- 2
Organon BioSciences General Information
Description
Manufacturer of pharmaceutical products. The company develops, manufactures and markets products targeting selected therapeutic areas in human pharmaceuticals and covering a wide range of species in animal health. It offers its products in the areas of cardiovascular disease, fertility, gynecology, anesthesia, respiratory, consumer health care and neuroscience, immunology, animal health and oncology.
Contact Information
Website
www.organon.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- Molenstraat 110
- 5342 CC Oss
- Netherlands
Organon BioSciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Organon BioSciences‘s full profile, request access.
Request a free trialOrganon BioSciences Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Antonius Wilderbeek | President & Chief Executive Officer |
Organon BioSciences Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Organon BioSciences‘s full profile, request access.
Request a free trialOrganon BioSciences Investments (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 & 0000000 | 22-May-2013 | 000000000 00000 00 | Buildings and Property | ||
| Kadmus Pharmaceuticals (FAAH Inhibitor Technology OSS) | 26-Jun-2007 | Corporate Asset Purchase | Buildings and Property | 00000000 0000000000 |